Viking Therapeutics, Inc.

This study tests a new medication called VK2735 to help people with obesity or overweight lose weight. About 4500 adults who are obese or overweight with related health issues (like high blood pressure) will receive weekly injections of the drug or a placebo for 78 weeks. The mai…

This study tests an investigational drug called VK2735 to help people with type 2 diabetes who are overweight or obese lose weight. About 1,100 adults will receive either the drug or a placebo injection weekly for 78 weeks. The main goal is to see how much weight they lose and if…